Montastruc, François

Hepatotoxicity Related to Agomelatine and Other New Antidepressants: A Case/Noncase Approach With Information From the Portuguese, French, Spanish, and Italian Pharmacovigilance Systems

Montastruc, F., Scotto, S., Vaz, I. R., Guerra, L. N., Escudero, A., Sáinz, M., Falomir, T., Bagheri, H., Herdeiro, M. T., Venegoni, M., et al. (2014) · Journal of Clinical Psychopharmacology

Drug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug Reactions

Cited by 33

Advantages and limitations of online communities of patients for research on health products

Ravoire, S., Lang, M., Perrin, E., Audry, A., Bilbault, P., Chekroun, M., Demerville, L., Escudier, T., Guéroult-Accolas, L., Guillot, C., et al. (2017) · Therapies

Health Literacy and Information AccessibilityPharmacovigilance and Adverse Drug Reactions

Cited by 31

Can large language models detect drug–drug interactions leading to adverse drug reactions?

Sicard, J., Montastruc, F., Achalme, C., Jonville-Bera, A. P., Songue, P., Babin, M., Soeiro, T., Schiro, P., de Canecaude, C., & Barus, R. (2025) · Therapeutic Advances in Drug Safety

Pharmacovigilance and Adverse Drug ReactionsArtificial Intelligence in Healthcare and Education

Cited by 29

Withdrawal syndrome after antipsychotics discontinuation: an analysis of the WHO database of spontaneous reports (Vigibase) between 2000 and 2022

Storck, W., de Laportalière, T. T., Yrondi, A., Javelot, H., Berna, F., & Montastruc, F. (2024) · Psychopharmacology

Schizophrenia research and treatmentPharmacovigilance and Adverse Drug Reactions

Cited by 10

Association between major cardiovascular events and esketamine: A disproportionality analysis in the WHO pharmacovigilance database

Taillefer de Laportalière, T., Horowitz, M. A., Soeiro, T., Lepetit, M., Jullien, A., Yrondi, A., Moncrieff, J., Naudet, F., & Montastruc, F. (2025) · European Neuropsychopharmacology

Pharmacovigilance and Adverse Drug ReactionsTreatment of Major Depression

Cited by 2